Literature DB >> 28587802

Cytokine filtration modulates pulmonary metabolism and edema formation during ex vivo lung perfusion.

Ilker Iskender1, Tugba Cosgun1, Stephan Arni1, Michael Trinkwitz2, Stefan Fehlings2, Yoshito Yamada1, Nikola Cesarovic3, Keke Yu4, Thomas Frauenfelder5, Wolfgang Jungraithmayr1, Walter Weder1, Ilhan Inci6.   

Abstract

BACKGROUND: Ex vivo lung perfusion (EVLP) has improved the process of donor lung management. Cytokine accumulation during EVLP has been shown to correlate with worse outcome after lung transplantation. Our objective in this study was to test the safety and efficacy of cytokine filtration during EVLP in a large animal model.
METHODS: Pig donor lungs were preserved for 24 hours at 4°C, followed by 12 hours of EVLP, according to the Toronto protocol. The perfusate was continuously run through an absorbent device (CytoSorb) via a veno-venous shunt from the reservoir in the filter group. EVLP was performed according to the standard protocol in the control group (n = 5 each). EVLP physiology, lung X-ray, perfusate biochemistry, inflammatory response and microscopic injury were assessed.
RESULTS: Cytokine filtration significantly improved airway pressure and dynamic compliance during the 12-hour perfusion period. Lung X-rays acquired at the end of perfusion showed increased consolidation in the control group. Electrolyte imbalance, determined by increased hydrogen, potassium and calcium ion concentrations in the perfusate, was markedly worsened in the control group. Glucose consumption and lactate production were markedly reduced, along with the lactate/pyruvate ratio in the filter group. Cytokine expression profile, tissue myeloperoxidase activity and microscopic lung injury were significantly reduced in the filter group.
CONCLUSIONS: Continuous perfusate filtration through sorbent beads is effective and safe during prolonged EVLP. Cytokine removal decreased the development of pulmonary edema and electrolyte imbalance through the suppression of anaerobic glycolysis and neutrophil activation in this setting. Further studies are needed to test the beneficial effect of cytokine filtration on post-transplant lung function.
Copyright © 2017 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cytokine filtration; cytosorb; ex vivo lung perfusion; ex vivo lung physiology; lung metabolism; lung resuscitation; lung transplantation

Year:  2017        PMID: 28587802     DOI: 10.1016/j.healun.2017.05.021

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  13 in total

Review 1.  Lung transplantation, ex-vivo reconditioning and regeneration: state of the art and perspectives.

Authors:  Lorenzo Rosso; Alberto Zanella; Ilaria Righi; Mario Barilani; Lorenza Lazzari; Eleonora Scotti; Francesca Gori; Paolo Mendogni
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 2.  Machine perfusion of thoracic organs.

Authors:  Dirk Van Raemdonck; Filip Rega; Steffen Rex; Arne Neyrinck
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 3.  Machine perfusion strategies in liver transplantation.

Authors:  Andrea Schlegel; Xavier Muller; Philipp Dutkowski
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

4.  Is perfusate exchange during ex vivo lung perfusion beneficial?

Authors:  Christina C Kao; Amit D Parulekar
Journal:  Ann Transl Med       Date:  2020-02

5.  Extended ex vivo lung perfusion-abridged expense.

Authors:  Harpreet Singh Grewal; Atul C Mehta; Alejandro Bribiesco
Journal:  Ann Transl Med       Date:  2020-02

6.  Multiday maintenance of extracorporeal lungs using cross-circulation with conscious swine.

Authors:  Ahmed E Hozain; Yuliya Tipograf; Meghan R Pinezich; Katherine M Cunningham; Rachel Donocoff; Dawn Queen; Kenmond Fung; Charles C Marboe; Brandon A Guenthart; John D O'Neill; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-17       Impact factor: 6.439

Review 7.  Current Status and Future Perspectives on Machine Perfusion: A Treatment Platform to Restore and Regenerate Injured Lungs Using Cell and Cytokine Adsorption Therapy.

Authors:  Anna Niroomand; Gabriel Hirdman; Franziska Olm; Sandra Lindstedt
Journal:  Cells       Date:  2021-12-29       Impact factor: 6.600

8.  Ex vivo lung perfusion with perfusate purification for human donor lungs following prolonged cold storage.

Authors:  Dong Wei; Fei Gao; Zhenkun Yang; Wei Wang; Yinglun Chen; Yan Lu; Jingyu Chen
Journal:  Ann Transl Med       Date:  2020-02

9.  Haemoadsorption reduces the inflammatory response and improves blood flow during ex vivo renal perfusion in an experimental model.

Authors:  Sarah A Hosgood; Tom Moore; Theresa Kleverlaan; Tom Adams; Michael L Nicholson
Journal:  J Transl Med       Date:  2017-10-25       Impact factor: 5.531

10.  Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model.

Authors:  Ilhan Inci; Stephan Arni; Ilker Iskender; Necati Citak; Josep Monné Rodriguez; Miriam Weisskopf; Isabelle Opitz; Walter Weder; Thomas Frauenfelder; Marie Pierre Krafft; Donat R Spahn
Journal:  Cells       Date:  2020-11-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.